Omega Reports Q1 Revenue of $322.955M, Exceeding Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 28 2026
0mins
Should l Buy OHI?
Reports Q1 revenue $322.955M, consensus $266.71M. Taylor Pickett, Omega's Chief Executive Officer, stated, "We are pleased to report strong first quarter results, with FAD per share up 9.5% over the same quarter last year. This reflects our continued accretive investment activity, augmented by active portfolio management. As a result of our strong start to 2026, we were able to increase the low end of our AFFO guidance, moving the midpoint up by two cents to $3.22."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OHI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OHI
Wall Street analysts forecast OHI stock price to fall
9 Analyst Rating
4 Buy
5 Hold
0 Sell
Moderate Buy
Current: 47.190
Low
42.00
Averages
46.44
High
50.00
Current: 47.190
Low
42.00
Averages
46.44
High
50.00
About OHI
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through a single segment, which invests in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). Its core portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. The Company's portfolio of real estate investments includes over 1,026 healthcare facilities, located in 42 states and the United Kingdom that are operated by 87 third-party operators.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Top Healthcare Stocks for Retirees
- Pfizer's Challenges and Opportunities: As an industry-leading pharmaceutical company, Pfizer faces challenges from multiple patent expirations, yet offers a high dividend yield of 6.5%; however, with a payout ratio exceeding 100%, it may be more suitable for aggressive investors.
- Medtronic's Transformation Journey: Medtronic boasts a 48-year streak of annual dividend increases with a current yield of 3.6%, as the company is restructuring by cutting costs and focusing on profitable divisions, which is expected to restore growth and enhance market valuation.
- Omega's Stable Returns: Omega Healthcare Investors focuses on senior housing properties and, despite facing difficulties during the pandemic, has maintained its dividend; with a current yield of 5.8%, the company is gradually recovering and is ideal for investors seeking stable income.
- Retiree Investment Choices: For retirees, Pfizer, Medtronic, and Omega Healthcare represent compelling high-yield healthcare stocks to consider, each offering distinct business models that can provide stable cash flow and potential long-term growth for investment portfolios.
See More
Investment Opportunities in Healthcare Stocks
- Pfizer's Challenges and Opportunities: As an industry-leading pharmaceutical company, Pfizer faces challenges from multiple patent expirations; however, with a current dividend yield of 6.5% and a payout ratio exceeding 100%, it is more suited for aggressive investors, while the company remains committed to long-term growth.
- Medtronic's Transformation Journey: Medtronic boasts a 48-year history of annual dividend increases, currently offering a 3.6% yield, as the company is restructuring by cutting costs and focusing on its most profitable divisions, with expectations to return to growth and achieve higher market valuations post-transition.
- Omega Healthcare's Stable Returns: Omega Healthcare, focusing on senior housing properties, has a 5.8% dividend yield and, despite challenges during the pandemic, has begun to recover its business, positioning itself to benefit from the growing demand of an aging population in the long term.
- Choices for Retired Investors: For retirees, Pfizer, Medtronic, and Omega Healthcare represent high-yield healthcare stocks worth considering; although they operate under different business models, they all provide stable cash flow and potential for long-term growth in an investment portfolio.
See More
Omega Healthcare Q1 2026 Earnings Highlights
- Strong Financial Performance: Omega Healthcare reported an adjusted funds from operations (AFFO) of $0.82 per share for Q1 2026, reflecting a year-over-year increase driven by acquisitions and active portfolio management, thereby enhancing the company's financial stability and market competitiveness.
- Capital Recycling Strategy: The company plans to complete $480 million in asset sales in Q2, a move that not only boosts liquidity but is also expected to generate approximately $0.03 of annual AFFO and FAD accretion, demonstrating flexibility in capital operations.
- Significant Revenue Growth: Q1 revenue reached $323 million, a 16.6% increase from $277 million in Q1 2025, indicating strong performance in the market and rising customer demand, further solidifying its position in the healthcare investment sector.
- Optimistic Outlook: The company narrowed its full-year adjusted AFFO guidance to a range of $3.19 to $3.25 per share, reflecting a $0.02 increase over the midpoint of previous guidance, showcasing management's confidence in future performance while acknowledging increased market competition and investment opportunities.
See More
Omega Healthcare Reports Increased Q1 Profit
- Profit Growth: Omega Healthcare Investors Inc. reported a first-quarter profit of $151.05 million, translating to $0.47 per share, which marks a significant increase from last year's $109.03 million and $0.33 per share, indicating strong performance in the healthcare investment sector.
- Revenue Increase: The company's revenue rose by 16.7% year-over-year to $322.96 million, up from $276.79 million last year, reflecting enhanced competitiveness and growing customer demand in the market.
- Financial Health: With continuous revenue growth and improved profitability, Omega Healthcare's financial condition has strengthened, enhancing its market position in healthcare investments and potentially attracting more investor interest.
- Market Outlook: As the healthcare industry continues to evolve, Omega Healthcare's profit and revenue growth provide a solid foundation for future expansion and investment, signaling the company's long-term growth potential within the sector.
See More
Omega Healthcare Reports Strong Q1 Earnings Despite Stock Decline
- Earnings Beat: Omega Healthcare Investors reported adjusted funds from operations (FFO) of $0.82 per diluted share for Q1, up from $0.75 a year ago and exceeding the consensus estimate of $0.79, indicating improved operational efficiency.
- Significant Revenue Growth: The company's revenue for the first quarter reached $322.96 million, up from $276.79 million a year earlier and surpassing the average analyst estimate of $266.71 million, reflecting strong market performance.
- Upgraded FFO Guidance: Omega now expects adjusted FFO per share for 2026 to be in the range of $3.19 to $3.25, an increase from the previous guidance of $3.15 to $3.25, demonstrating confidence in future performance.
- Stable Rent Payments: Despite Genesis Healthcare's bankruptcy protection, Omega anticipates it will continue to pay its contractual rent obligations of $13.3 million per quarter, while Maplewood Senior Living paid $19.4 million in rent this quarter, indicating tenant stability supporting the company's finances.
See More
Omega Healthcare Investors Declares Cash Dividend of $0.67
- Dividend Declaration: Omega Healthcare Investors, Inc. has declared a cash dividend of $0.67 per share, payable on May 15, 2026, which aims to provide shareholders with a stable return and enhance investor confidence in the company.
- Record Date for Shareholders: The record date for this dividend is set for May 4, 2026, ensuring that shareholders who own stock by this date will receive the dividend, thereby promoting stability in shareholder ownership.
- Investment Focus: As a real estate investment trust, Omega focuses on the long-term healthcare industry, primarily investing in skilled nursing and assisted living facilities, which highlights its strategic positioning and market focus in the healthcare sector.
- Diverse Asset Portfolio: The company's asset portfolio spans various healthcare companies across the US, UK, and Canada, utilizing a triple-net lease structure, demonstrating its market penetration capabilities and risk diversification strategy across different regions.
See More
Top Healthcare Stocks for Retirees
- Pfizer's Challenges and Opportunities: As an industry-leading pharmaceutical company, Pfizer faces challenges from multiple patent expirations, yet offers a high dividend yield of 6.5%; however, with a payout ratio exceeding 100%, it may be more suitable for aggressive investors.
- Medtronic's Transformation Journey: Medtronic boasts a 48-year streak of annual dividend increases with a current yield of 3.6%, as the company is restructuring by cutting costs and focusing on profitable divisions, which is expected to restore growth and enhance market valuation.
- Omega's Stable Returns: Omega Healthcare Investors focuses on senior housing properties and, despite facing difficulties during the pandemic, has maintained its dividend; with a current yield of 5.8%, the company is gradually recovering and is ideal for investors seeking stable income.
- Retiree Investment Choices: For retirees, Pfizer, Medtronic, and Omega Healthcare represent compelling high-yield healthcare stocks to consider, each offering distinct business models that can provide stable cash flow and potential long-term growth for investment portfolios.
See More
Investment Opportunities in Healthcare Stocks
- Pfizer's Challenges and Opportunities: As an industry-leading pharmaceutical company, Pfizer faces challenges from multiple patent expirations; however, with a current dividend yield of 6.5% and a payout ratio exceeding 100%, it is more suited for aggressive investors, while the company remains committed to long-term growth.
- Medtronic's Transformation Journey: Medtronic boasts a 48-year history of annual dividend increases, currently offering a 3.6% yield, as the company is restructuring by cutting costs and focusing on its most profitable divisions, with expectations to return to growth and achieve higher market valuations post-transition.
- Omega Healthcare's Stable Returns: Omega Healthcare, focusing on senior housing properties, has a 5.8% dividend yield and, despite challenges during the pandemic, has begun to recover its business, positioning itself to benefit from the growing demand of an aging population in the long term.
- Choices for Retired Investors: For retirees, Pfizer, Medtronic, and Omega Healthcare represent high-yield healthcare stocks worth considering; although they operate under different business models, they all provide stable cash flow and potential for long-term growth in an investment portfolio.
See More
Omega Healthcare Q1 2026 Earnings Highlights
- Strong Financial Performance: Omega Healthcare reported an adjusted funds from operations (AFFO) of $0.82 per share for Q1 2026, reflecting a year-over-year increase driven by acquisitions and active portfolio management, thereby enhancing the company's financial stability and market competitiveness.
- Capital Recycling Strategy: The company plans to complete $480 million in asset sales in Q2, a move that not only boosts liquidity but is also expected to generate approximately $0.03 of annual AFFO and FAD accretion, demonstrating flexibility in capital operations.
- Significant Revenue Growth: Q1 revenue reached $323 million, a 16.6% increase from $277 million in Q1 2025, indicating strong performance in the market and rising customer demand, further solidifying its position in the healthcare investment sector.
- Optimistic Outlook: The company narrowed its full-year adjusted AFFO guidance to a range of $3.19 to $3.25 per share, reflecting a $0.02 increase over the midpoint of previous guidance, showcasing management's confidence in future performance while acknowledging increased market competition and investment opportunities.
See More
Omega Healthcare Reports Increased Q1 Profit
- Profit Growth: Omega Healthcare Investors Inc. reported a first-quarter profit of $151.05 million, translating to $0.47 per share, which marks a significant increase from last year's $109.03 million and $0.33 per share, indicating strong performance in the healthcare investment sector.
- Revenue Increase: The company's revenue rose by 16.7% year-over-year to $322.96 million, up from $276.79 million last year, reflecting enhanced competitiveness and growing customer demand in the market.
- Financial Health: With continuous revenue growth and improved profitability, Omega Healthcare's financial condition has strengthened, enhancing its market position in healthcare investments and potentially attracting more investor interest.
- Market Outlook: As the healthcare industry continues to evolve, Omega Healthcare's profit and revenue growth provide a solid foundation for future expansion and investment, signaling the company's long-term growth potential within the sector.
See More
Omega Healthcare Reports Strong Q1 Earnings Despite Stock Decline
- Earnings Beat: Omega Healthcare Investors reported adjusted funds from operations (FFO) of $0.82 per diluted share for Q1, up from $0.75 a year ago and exceeding the consensus estimate of $0.79, indicating improved operational efficiency.
- Significant Revenue Growth: The company's revenue for the first quarter reached $322.96 million, up from $276.79 million a year earlier and surpassing the average analyst estimate of $266.71 million, reflecting strong market performance.
- Upgraded FFO Guidance: Omega now expects adjusted FFO per share for 2026 to be in the range of $3.19 to $3.25, an increase from the previous guidance of $3.15 to $3.25, demonstrating confidence in future performance.
- Stable Rent Payments: Despite Genesis Healthcare's bankruptcy protection, Omega anticipates it will continue to pay its contractual rent obligations of $13.3 million per quarter, while Maplewood Senior Living paid $19.4 million in rent this quarter, indicating tenant stability supporting the company's finances.
See More
Omega Healthcare Investors Declares Cash Dividend of $0.67
- Dividend Declaration: Omega Healthcare Investors, Inc. has declared a cash dividend of $0.67 per share, payable on May 15, 2026, which aims to provide shareholders with a stable return and enhance investor confidence in the company.
- Record Date for Shareholders: The record date for this dividend is set for May 4, 2026, ensuring that shareholders who own stock by this date will receive the dividend, thereby promoting stability in shareholder ownership.
- Investment Focus: As a real estate investment trust, Omega focuses on the long-term healthcare industry, primarily investing in skilled nursing and assisted living facilities, which highlights its strategic positioning and market focus in the healthcare sector.
- Diverse Asset Portfolio: The company's asset portfolio spans various healthcare companies across the US, UK, and Canada, utilizing a triple-net lease structure, demonstrating its market penetration capabilities and risk diversification strategy across different regions.
See More
